Musician Carly Simon became the latest in a lineup of well-known names to announce she has Parkinson's disease. Find out more about famous people with this neurological disorder.

“You can shrivel up and die ... or you can stand up and say, ‘I’m gonna live,’ Crews told Tamron Hall ...

On Monday, Sept. 28, the U.S. Food and Drug Administration approved a new treatment that targets dopamine pathways critical to those living with the disease.

A nationwide Medicare study found a clear distance-response pattern between residential proximity to dry cleaners and Parkinson’s disease, raising new questions about the potential role of ...

In the Phase 3 TEMPO program, AbbVie’s Juvmo elicited significant improvements in motor symptoms and prolonged periods with ...

The singer-songwriter will release her first original album in 18 years, ‘Comes in Waves,’ on Aug. 14 Carly Simon has been living with Parkinson’s disease, she revealed July 27 in a statement obtained ...

Can a skin test diagnose Parkinson’s Disease? The very latest in Parkinson’s research including a skin test to diagnose the disease and a probiotic that could eliminate the need multiple daily doses.

If living near a golf course seems scenic and relaxing, it may also be linked to a higher risk of Parkinson’s disease, according to a surprising new study that comes with some limitations. Led by the ...

The FDA has approved Juvmo, the first and only dopamine agonist for adults with Parkinson’s disease designed to selectively ...

Please provide your email address to receive an email when new articles are posted on . Improper disposal of chlorinated solvents can lead to contamination near dry cleaners. The association between ...

JUVMO™ is the first and only selective D1/D5 receptor agonist approved for adults with Parkinson's disease1 Taken once daily with or without levodopa therapy, JUVMO offers patients ...

Tavapadon (Juvmo) is the first selective D1/D5 dopamine receptor agonist approved for adult Parkinson disease, positioning a mechanistically differentiated oral, once-daily dopaminergic strategy.